An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

NCT02854436 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

289

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Niraparib

Sponsor

Janssen Research & Development, LLC